1.

57例NSCLC患者LVD和MVD与各临床病理特征之间的关系

The relationship between LVD、MVD and clincopathological parameters

Characteristic	n	CD31	t	P		CD34	t	P		LVD	t	P
Sex			0.862	0.392			0.084	0.933			0.554	0.584
Male	46	28.72±11.0				35.02±12.71				16.76±7.15
Female	11	31.82±9.25				35.36±9.00				17.64±3.91
Age (year)			0.224	0.824			0.208	0.836			0.232	0.817
> 55	37	29.08±11.68				35.30±13.87				17.08±6.58
≤55	20	29.75±8.84				34.70±7.80				16.65±6.87
Smoking			0.007	0.995			0.289	0.773			0.551	0.584
Yes	34	29.32±10.90				34.71±12.87				16.53±6.16
No	23	29.30±10.61				35.65±10.88				17.52±7.37
Location			0.132	0.895			0.605	0.547			0.950	0.346
Center	42	29.43±11.16				35.67±12.60				17.43±6.69
Periphery	15	29.00±9.58				33.47±10.43				15.53±6.47
Histologic classification			0.052	0.959			0.981	0.331			0.935	0.354
Squamous cancer	32	29.25±12.01				36.47±13.91				17.66±6.96
Non-squamous cancer	25	29.40±8.96				33.32±9.00				16.00±6.19
Differentiation			1.168	0.248			1.034	0.306			0.287	0.775
Moderate+well	39	30.44±10.26				36.21±11.24				17.10±6.22
Poor	18	26.89±11.48				32.67±13.57				16.56±7.63
Stage			2.271	0.027			2.106	0.040			3.566	0.001
Ⅰ+Ⅱ	34	26.76±10.56				32.41±11.66				14.59±6.45
Ⅲ+Ⅳ	23	33.09±10.93				39.04±11.67				20.39±5.32
Lymph node metastasis			3.239	0.002			2.553	0.013			6.025	< 0.001
N0	28	25.00±8.93				31.14±10.65				12.71±4.78
N1+N2	29	33.48±10.73				38.90±12.20				21.00±5.56